
Novel allosteric PGAM1 ингибитор, showing efficacious in multiple preclinical models of pancreatic ductal adenocarcinoma (PDAC), especially with high PGAM1 expression
Novel allosteric PGAM1 inhibitor, showing efficacious in multiple preclinical models of pancreatic ductal adenocarcinoma (PDAC), especially with high PGAM1 expression
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.